Case report: Disseminated herpes simplex virus 1 infection and hemophagocytic lymphohistiocytosis after immunomodulatory therapy in a patient with coronavirus disease 2019

Corticosteroids and immunomodulatory therapies are widely used to treat patients with severe coronavirus disease 2019 (COVID-19). Janus kinase (JAK) inhibitors such as tofacitinib have been recently studied as adjuvants in the treatment of COVID-19. Although immunomodulatory therapies may be linked...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzotta, Elvio, Fiorda Diaz, Juan, Echeverria-Villalobos, Marco, Eisinger, Gregory, Sprauer, Sarah, Singha, Arindam, Lyaker, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720054/
https://www.ncbi.nlm.nih.gov/pubmed/36479095
http://dx.doi.org/10.3389/fmed.2022.1053012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720054/
https://www.ncbi.nlm.nih.gov/pubmed/36479095
http://dx.doi.org/10.3389/fmed.2022.1053012

Ejemplares similares